Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 27.78 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $10.224 million which missed the analyst consensus estimate of $11.063 million by 7.59 percent. This is a 14.27 percent decrease over sales of $11.926 million the same period last year.